Il y a eu 50 transactions d'initiés récentes enregistrées pour Keros Therapeutics, Inc. (KROS), dont 23 achats et 16 ventes. Le total des achats d'initiés s'élève à $17.44M et le total des ventes d'initiés à $23.86M.
Les initiés notables ayant une activité récente comprennent Seehra Jasbir, Bienaime Jean Jacques, Newton Charles W.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — KROS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-02 |
Seehra Jasbir |
Chief Executive Officer |
Exercice d'Options (Vente) |
55,000 |
$0.30 |
$16.5K |
197,444 |
| 2026-03-09 |
Bienaime Jean Jacques |
Director |
Achat Informatif |
2,000 |
$11.21 |
$22.42K |
7,450 |
| 2026-03-09 |
Newton Charles W. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-09 |
Newton Charles W. |
Director |
Attribution de RSU |
13,215 |
- |
- |
13,215 |
| 2026-02-24 |
Regnante Keith |
Chief Financial Officer |
Attribution de RSU |
60,000 |
$15.52 |
$931.2K |
60,000 |
| 2026-02-24 |
Seehra Jasbir |
Chief Executive Officer |
Attribution de RSU |
100,000 |
$15.52 |
$1.55M |
100,000 |
| 2026-02-24 |
Cho Esther |
Chief Legal Officer |
Attribution de RSU |
80,000 |
$15.52 |
$1.24M |
80,000 |
| 2026-02-19 |
Seehra Jasbir |
Chief Executive Officer |
Vente Informative |
7,015 |
$16.17 |
$113.43K |
385,708 |
| 2026-02-18 |
Regnante Keith |
Chief Financial Officer |
Vente Informative |
4,739 |
$16.35 |
$77.48K |
39,261 |
| 2026-02-18 |
Lerner Lorena Raquel |
Chief Science Officer |
Vente Informative |
3,873 |
$16.35 |
$63.32K |
31,127 |
| 2026-02-18 |
Cho Esther |
SVP, General Counsel |
Vente Informative |
4,745 |
$16.35 |
$77.58K |
39,755 |
| 2026-01-07 |
Seehra Jasbir |
Chief Executive Officer |
Attribution de RSU |
62,500 |
$63.61 |
$3.98M |
62,500 |
| 2025-11-21 |
Orbimed Advisors Llc |
Director |
Restitution d'Actions |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Gordon Carl L |
Director |
Restitution d'Actions |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Knowles Julius |
Director |
Restitution d'Actions |
130,494 |
$17.75 |
$2.32M |
102,233 |
| 2025-10-15 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Vente Informative |
743,358 |
$17.75 |
$13.19M |
- |
| 2025-10-15 |
Pontifax Management 4 G.p. (2015) Ltd. |
10 Percent Owner |
Vente Informative |
155,262 |
$17.75 |
$2.76M |
- |
| 2025-09-03 |
Seehra Jasbir |
Chief Executive Officer |
Attribution de RSU |
90,500 |
- |
- |
392,723 |
| 2025-08-06 |
Lerner Lorena Raquel |
Chief Science Officer |
Inconnu |
10,879 |
$43.99 |
$478.57K |
- |
| 2025-08-06 |
Cho Esther |
SVP, General Counsel |
Inconnu |
50,000 |
$54.38 |
$2.72M |
- |
| 2025-06-20 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Exercice d'Options (ITM) |
1 |
$60.00 |
$60.00 |
- |
| 2025-06-04 |
Bienaime Jean Jacques |
Director |
Attribution de RSU |
5,250 |
- |
- |
5,450 |
| 2025-06-04 |
Gray Mary Ann |
Director |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Gordon Carl L |
Director |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Kariv Tomer |
10 Percent Owner |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Nussbaum Ran |
10 Percent Owner |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Seth Alpna |
Director |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Farzan Nima |
Director |
Attribution de RSU |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Knowles Julius |
Director |
Attribution de RSU |
5,250 |
- |
- |
6,441 |
| 2025-06-04 |
Kariv Tomer |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-06-04 |
Nussbaum Ran |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-05-16 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Option Expirée |
178 |
$10.00 |
$1.78K |
- |
| 2025-04-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Autre (Vente) |
74,333 |
- |
- |
50,000 |
| 2025-04-08 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
949,333 |
- |
- |
- |
| 2025-04-04 |
Seehra Jasbir |
Chief Executive Officer |
Exercice d'Options (Vente) |
49,367 |
$0.30 |
$14.81K |
252,444 |
| 2025-04-03 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
17,800 |
$10.00 |
$178K |
- |
| 2025-02-18 |
Regnante Keith |
Chief Financial Officer |
Attribution de RSU |
44,000 |
- |
- |
44,000 |
| 2025-02-18 |
Rovaldi Christopher |
Chief Operating Officer |
Attribution de RSU |
60,000 |
- |
- |
60,000 |
| 2025-02-18 |
Chyung Yung H. |
Chief Medical Officer |
Attribution de RSU |
44,000 |
- |
- |
44,000 |
| 2024-11-08 |
Chyung Yung H. |
Chief Medical Officer |
Attribution de RSU |
110,000 |
$67.91 |
$7.47M |
110,000 |
| 2024-11-01 |
Chyung Yung H. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-10-02 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
100 |
$60.00 |
$6K |
- |
| 2024-10-01 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
200 |
$70.00 |
$14K |
- |
| 2024-08-13 |
Orbimed Advisors Llc |
Director |
Vente Informative |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-08-13 |
Gordon Carl L |
Director |
Vente Informative |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-06-03 |
Bienaime Jean Jacques |
Director |
Attribution de RSU |
17,600 |
$48.67 |
$856.59K |
17,600 |
| 2024-06-01 |
Bienaime Jean Jacques |
Director |
Cession |
- |
- |
- |
200 |
| 2024-05-30 |
Gray Mary Ann |
Director |
Attribution de RSU |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Gordon Carl L |
Director |
Attribution de RSU |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Kariv Tomer |
10 Percent Owner |
Attribution de RSU |
10,000 |
$46.31 |
$463.1K |
10,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
